AMERICAN SOCIETY OF NEPHROLOGY (ASN) COMMITS $2,700,000 TO ITS NEW LOAN MITIGATION PILOT PROGRAM FOCUSED ON BUILDING EXCELLENCE IN NEPHROLOGY

• The five-year innovative pilot program offers financial support for trainees entering the field of nephrology, focusing on individuals historically underrepresented in medicine.
• Six candidates selected in the first year of the program will each receive $50,000 over the course of three years toward the repayment of eligible student loans.

Advocates from ASN Urges Congress to Change the Status Quo in Kidney Health

• More than 37 million Americans live with kidney diseases.
• 800,000 Americans have kidney failure, a condition for which there is no cure.
• Kidney diseases disproportionately affect communities of color.
• COVID-19, especially deadly for people with kidney diseases, has highlighted the urgent need for change

AMERICAN SOCIETY OF NEPHROLOGY LEADS EFFORTS TO ADVANCE EQUITABLE DISTRIBUTION OF COVID-19 VACCINES TO DIALYSIS PATIENTS

Washington, DC (February 25, 2021) —The American Society of Nephrology (ASN) is spearheading efforts to secure direct federal allocation of COVID-19 vaccines to dialysis patients and frontline dialysis workers. This allocation would improve access for a vulnerable patient population, more than half of whom are Black, Hispanic, Asian, Native American, and Native Hawaiian or other Pacific Islanders (NHPIs).

KIDNEYCURE ANNOUNCES 2020 GRANT RECIPIENTS

• Kidney diseases affect more than 850 million people worldwide.

• KidneyCure continues to propel positive change in public health, once again funding more than $3 million to support research that changes lives.

• This year’s grant recipients, among the best and the brightest in the field, bring energy, innovation and expertise to areas undergoing rapid change: acute kidney injury and repair, home dialysis, and post-transplant care.

KIDNEY HEALTH INITIATIVE URGES INVESTIGATORS TO INCLUDE PEOPLE WITH KIDNEY DISEASES IN CLINICAL TRIALS FOR CORONAVIRUS 2019 (COVID-19) THERAPIES

People with kidney diseases are often excluded from clinical trials because of the complexity and high morbidity of kidney disease.

COVID-19 puts people with kidney diseases at a two to sixteen-fold increased risk of severe symptoms.

All investigators should include people with kidney diseases when developing vaccines, preventative therapies or treatments related to COVID-19.

AMERICAN SOCIETY OF NEPHROLOGY TRANSPLANT POLICY PRIORITIES AT CENTER OF BOLD NEW PROPOSED RULES

The US Department of Health and Human Services (HHS) today took bold steps in two proposed rules to increase the availability of organs for the 113,000 Americans waiting for a lifesaving organ transplant – 20 of whom die each day – and to strengthen support for Americans who choose to be living donors. Both proposed rules advance policy changes the American Society of Nephrology has long been advocating for and is strongly supportive of.

STATEMENT OF AMERICAN SOCIETY OF NEPHROLOGY PRESIDENT MARK E. ROSENBERG, MD, FASN, ON THE KIDNEY CARE CHOICES MODEL ASN welcomes “visionary approach for the future of kidney care.”

American Society of Nephrology President Mark E. Rosenberg, MD, FASN, has issued the following statement regarding the new Kidney Care Choices Model:

“The American Society of Nephrology (ASN) welcomes the introduction of the voluntary Kidney Care Choices (KCC) Model, and its four kidney care payment options, addressing key aspects of the Executive Order on Advancing American Kidney Health (AAKH). This voluntary model will be a true game changer and brings desperately needed, sweeping changes to care for people with kidney diseases. ASN has long advocated for key elements of this model, and I thank HHS Secretary Azar and his entire team for putting forward such a visionary approach for the future of kidney care.

KIDNEYX INTRODUCES STEERING COMMITTEE

The U.S. Department of Health and Human Services (HHS) Office of the Chief Technology Officer and the American Society of Nephrology (ASN) today introduced the members of the newly formed KidneyX Innovation Accelerator (KidneyX) steering committee. This diverse group of experts will play a critical role in advancing the KidneyX mission to improve the lives of the 850,000,000 people worldwide currently affected by kidney diseases by accelerating innovation in kidney disease prevention, diagnostics, and treatment.